Using an artificial intelligence (AI) model to standardize and analyze a massive, global set of whole genome sequencing (WGS) data for Cronobacter sakazakii, University of Maryland researchers have discovered genetic traits that may explain the pathogen’s persistence and virulence in low-moisture foods like powdered infant formula.
FDA has outlined a list of actions it intends to take to improve the timeliness and transparency of food product recalls. The agency specifically called on the infant formula and baby food industry to cooperate in “creating a collaborative transformation in how we manage and communicate food recalls.”
Chinese lawmakers are reviewing a draft amendment to the Food Safety Law addressing key food safety issues and regulatory oversight of the country's food industry.
The fiscal 2026 budget request from the U.S. Department of Health and Human Services touches on infant formula, ultra-processed foods, and other HHS priorities that Food Safety Magazine has reported on.
Traditionally, food safety laboratories have performed separate tests for each pathogen, which boosts costs and delays results. Hygiena’s Salmonella plus Cronobacter Detection LyoKit eliminates this inefficiency by detecting both pathogens in a single test.
FDA is launching “Operation Stork Speed,” comprising a series of actions like increased contaminant testing, to better ensure the safety and adequacy of the U.S. infant formula supply. Consumer Reports, which says Operation Stork Speed was announced one day after it shared contaminant testing results with the agency, has questioned whether FDA is adequately resourced to deliver on its new promises.
Recently reintroduced to Congress, the bipartisan Protect Infant Formula From Contamination Act aims to strengthen FDA’s oversight of infant formula manufacturers by expanding certain authorities, allowing the agency to better ensure the safety and resiliency of the country’s infant formula supply.
The U.S. Food and Drug Administration (FDA) has published a Long-Term National Strategy to Increase the Resiliency of the U.S. Infant Formula Market, building upon actions taken by the agency and implementing learnings from research conducted since the 2022 infant formula supply crisis.
The U.S. Food and Drug Administration (FDA) has issued a draft guidance for industry regarding the requirement to notify the agency in the case of a permanent discontinuance or an interruption of the manufacture of an infant formula product.
